Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.33 Mn | 643.20 Mn | 93.47 Mn | 70.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.75% |
| Mar 31, 2026 | 56.74% |
| Dec 31, 2025 | 456.55% |
| Sep 30, 2025 | -47.98% |
| Jun 30, 2025 | -48.36% |
| Mar 31, 2025 | -40.09% |
| Dec 31, 2024 | -114.33% |
| Sep 30, 2024 | 13.73% |
| Jun 30, 2024 | 55.16% |
| Mar 31, 2024 | 50.45% |
| Dec 31, 2023 | 259.18% |
| Sep 30, 2023 | 86.40% |
| Jun 30, 2023 | 1,879.94% |
| Mar 31, 2023 | -29.85% |
| Dec 31, 2022 | -60.07% |
| Sep 30, 2022 | 364.65% |
| Jun 30, 2022 | -108.22% |
| Mar 31, 2022 | 165.61% |
| Dec 31, 2021 | 10.83% |
| Sep 30, 2021 | -445.56% |